Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition. [electronic resource]
Producer: 20161011Description: 444-454 p. digitalISSN:- 1768-3254
- Animals
- Diabetes Mellitus, Experimental -- drug therapy
- Diabetes Mellitus, Type 2 -- drug therapy
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Enzyme Inhibitors -- chemical synthesis
- Glucose -- analogs & derivatives
- Glycogen Phosphorylase -- antagonists & inhibitors
- Hypoglycemic Agents -- chemical synthesis
- Isoxazoles -- chemical synthesis
- Molecular Structure
- Rats
- Rats, Zucker
- Spiro Compounds -- chemical synthesis
- Structure-Activity Relationship
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.